When a materials manager receives two vials from different deliveries, the useful question is not whether the packaging looks identical. It is whether each vial can be tied to a documented batch, a specific certificate of analysis (CoA), and the supplier’s UK release process. Research Sciences describes its research peptides as manufactured by international partners using solid-phase peptide synthesis (SPPS), with final verification and quality checks in the UK before release. For laboratory researchers, that description matters because it separates manufacturing origin from release control. It also explains why two documented batches should be compared through their records, not through cap colour, a marketing purity line, or an assumption that a restock is the same production lot. All materials discussed here are research-use-only and are not for human or veterinary use.
What the Supplier Says About SPPS Partners and Batch Documentation
Solid-phase peptide synthesis is a manufacturing route in which the peptide chain is assembled on a solid support and then cleaved and processed. Research Sciences states that its compounds are manufactured by international partners using SPPS, independently tested by HPLC, and subject to final verification and quality checks in the UK before release. The published FAQ position is that every product includes a CoA covering purity and identity, and that exact purity is stated on the CoA rather than reduced to one universal figure. The homepage also lists “CoAs Janoshik Analytical Reports”; where that wording appears, the researcher should open the actual CoA supplied with the specific batch and read the report that accompanies it. The shop’s broader documentation describes batch-level analytical verification supporting purity, identity and contaminant screening, with heavy metals and endotoxin evaluation described as part of an expanded testing framework.
When two documented batches are compared, the first control is the batch record. Vial labels use a reference format that combines the SKU code and expiry date, such as BPC10-03/27, and that reference links to the corresponding CoA. A materials manager should quote this reference when contacting the supplier about documentation. The second control is the Internal Test Reference (ITR). The supplier’s FAQ notes that restocked products may carry the same ITR as earlier stock. An ITR links to associated sample testing reports; it does not confirm that separate deliveries come from the same production lot or that each delivery has had separate independent testing. This is a crucial distinction when comparing two batches: a shared ITR is a documentation pointer, not proof of identical manufacturing history. Vial cap colours and other packaging may vary, and cap colour is not an indicator of identity, analytical quality or manufacturing origin.
For clarity, two documented batches means two batch-specific records for the same catalogue item, not two different products. A BPC-157 10mg label and a TB-500 5mg label identify different catalogue items; each requires its own product page and CoA. Even two deliveries of the same item should be compared by label reference, CoA and any ITR note, not by visual similarity. The published catalogue examples include Tesamorelin 5mg, TB-500 5mg, Ipamorelin 5mg, CJC-1295 (No DAC) 5mg, GHK-Cu 50mg and BPC-157 10mg, but the comparison principle is the same: follow the batch document for that vial. All items remain research-use-only and are not for human or veterinary use.
UK Release Checks When Two Batches Are Compared
The UK release check is described by the supplier as final verification and quality checks before release, not as a replacement for the partner’s SPPS manufacturing record. The homepage uses the published wording “≥99% Verified Purity” and “UK Research Materials Over 99.1% Purity”, alongside claims such as “3,000+ UK Orders” and “24hr UK Delivery”. These are current site-published figures and marketing lines, not independently audited batch results, and they should be reconfirmed on the live site and, where relevant, against the CoA for the exact batch. When two documented batches are compared, a single homepage purity figure is therefore less useful than the two batch-specific CoAs. The FAQ position is that peptides are typically supplied at ≥99% purity by HPLC, with the exact purity stated on the CoA.
The release check should also be read alongside the supplier’s description of contaminant screening. The About page describes full-spectrum testing as purity, identity, heavy metals and endotoxin evaluation of submitted samples, while the FAQ describes every compound as including a CoA for purity and identity, manufactured by international partners using SPPS and independently tested by HPLC before UK final verification. No researcher should invent pass/fail limits that are not printed on the report. If a CoA lists Janoshik Analytical Reports, the researcher should check the actual report that accompanies that batch rather than assuming all reports share one method, one date or one result. In a two-batch comparison, the relevant questions are: which catalogue item, which label reference, which CoA, which ITR note, and which analytical report belongs to that vial.
A practical comparison of two documented batches should therefore place the CoAs side by side. Check the product identity, the stated purity and the accompanying contaminant information as printed. Note whether the two vials share an ITR, but do not treat a shared ITR as proof of a shared production lot. Note any packaging variation, but do not treat cap colour as an identity or quality marker. If the documentation appears incomplete, quote the label reference and ask the supplier to clarify the batch record. This is the supplier’s described model: partner manufacture under SPPS, independent HPLC testing, UK final verification, and a CoA linked to the supported product. All materials remain research-use-only and are not for human or veterinary use.
A Practical Comparison Workflow for Materials Managers
Start with the catalogue item and the product page, not with a remembered purity figure. The all-products listing is the natural place to review the current research catalogue; from there, a researcher can Buy peptides uk materials only after confirming the exact item, then open the individual product record and its batch CoA. For each vial, record the SKU and expiry reference from the label, such as BPC10-03/27, and attach the corresponding CoA. If two documented batches are being assessed for an in-vitro study, keep the two records separate. Compare identity, stated purity, report source and any ITR note. Do not merge the two batches into one internal reference unless the supplier’s documentation supports that step.
After the documentation check, the laboratory workflow should remain controlled. Allow vials to reach room temperature before opening, work in a clean environment, and remove only the amount required for the experiment. Lyophilised peptides should be stored at –20°C or below, sealed with desiccant and protected from moisture, heat and light. Avoid repeated freeze–thaw cycles. Reconstituted peptides are less stable and should be stored at 2–8°C for short-term laboratory use. If a reconstitution calculator is used, it is for laboratory research only and must not be used for human or veterinary dosing. These handling points do not change the batch comparison: the CoA and label reference remain the primary documents.
Finally, materials managers should treat catalogue examples such as GHK-Cu 50mg or CJC-1295 (No DAC) 5mg as separate product records with separate documentation, not as interchangeable batches. The same applies to two deliveries of the same item: compare the label reference, the CoA and any ITR note, then confirm the current published wording on the live product page. Where a figure such as purity is quoted, it should be reconfirmed against the batch CoA rather than assumed from the homepage. All products are supplied for controlled laboratory and analytical research only, are not medicines or food supplements, and are not for human or veterinary use.
Lyon pastry chemist living among the Maasai in Arusha. Amélie unpacks sourdough microbiomes, savanna conservation drones, and digital-nomad tax hacks. She bakes croissants in solar ovens and teaches French via pastry metaphors.